Topic Paragraphs
Donate COVID-19 Plasma
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Aug 04
Roque Plast S.A. de C.V. Issues Voluntary Nationwide Recall of Command Brands Gel AntiBac Instant Hand Sanitizer Lots 200371-12, 200371OH-05, 170420OH-06, 170420OH-8 Due to Potential Presence of Methanol (Wood Alcohol)
Drugs
Aug 03
H-E-B Issues Recall for Blue Cheese Salmon Burgers Due to Undeclared Wheat
Food & Beverages
Aug 01
Thomson International Inc. Conducts Voluntary Recall of Red, Yellow, White, and Sweet Yellow Onions Because of Possible Salmonella Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Investing in Advanced Manufacturing to Support Public Health Preparedness
For the past several years, the U.S. Food and Drug Administration has sought to encourage and facilitate the adoption of Advanced Manufacturing.
Potential Risks of Treatment with Unapproved Regenerative Medicine Products
FDA is providing resources to help consumers understand the risks associated with unapproved stem cell, exosome, and products marketed as regenerative medicine.
FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
FDA's actions are providing stakeholders with more accurate information about diagnostic test performance and allowing for the rapid availability of new tests.
Recently Published Guidances
Aug 05
Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
Biologics, Drugs
Aug 04
Guidance for Industry: Action Level for Inorganic Arsenic in Rice Cereals for Infants
Food & Beverages
Jul 31
Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans
Biologics, Drugs